APA (7th ed.) Citation

Boustani, M., Garrison, L., Smolen, L., Belger, M., Klein, T., Murphy, D., . . . Johnston, J. (2022). EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease. Value in Health, 25(7), S385. https://doi.org/10.1016/j.jval.2022.04.510

Chicago Style (17th ed.) Citation

Boustani, M., LP Garrison, L. Smolen, M. Belger, TM Klein, DR Murphy, RT Burge, and J. Johnston. "EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease." Value in Health 25, no. 7 (2022): S385. https://doi.org/10.1016/j.jval.2022.04.510.

MLA (9th ed.) Citation

Boustani, M., et al. "EE263 Impact of Treatment Duration on the Potential Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Early Symptomatic Alzheimer's Disease." Value in Health, vol. 25, no. 7, 2022, p. S385, https://doi.org/10.1016/j.jval.2022.04.510.